{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:56:23Z","timestamp":1785430583777,"version":"3.56.0"},"reference-count":40,"publisher":"Royal College of Psychiatrists","issue":"3","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["BJPsych open"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec id=\"S2056472426110217_as1\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The PReDicT study showed that predictive algorithm-guided antidepressant treatment reduces anxiety and improves functioning in patients with depression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S2056472426110217_as2\">\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To estimate the costs, outcomes and cost-effectiveness of the PReDicT test compared with treatment as usual (TAU) for primary depression care in five European countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S2056472426110217_as3\">\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Within-trial economic analysis was conducted over 24 weeks from the health\/social care and societal perspectives alongside the PReDicT trial (NCT02790970) in France, Germany, The Netherlands, Spain, and the UK, according to Consolidated Health Economic Evaluation Reporting Standards guidelines. We calculated quality-adjusted life-years (QALYs) based on the EQ-5D-5L, capability-weighted life-years based on the Oxford Capabilities Questionnaire \u2013 Mental Health (OxCAP-MH) (Germany and UK only), and costs for 2018 (\u20ac). Multiple imputation for missing data, multivariable regression for cost and outcome differences, and bootstrapping and sensitivity analyses for uncertainty were conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S2056472426110217_as4\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were significant outcome improvements (EQ-5D-5L PRedicT: +0.139; TAU: +0.140) and societal cost reductions (PRedicT: \u2212\u20ac2589; TAU: \u2212\u20ac2602) in both groups (\n                      <jats:italic>N<\/jats:italic>\n                      = 913) between the before and during trial periods. In the UK and Germany (\n                      <jats:italic>n<\/jats:italic>\n                      = 619), the PReDicT group showed significant additional capability well-being gains (OxCAP-MH: +2.127,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.021). Cost-effectiveness probabilities ranged from 46 to 59% at trial level, but exceeded 80% in the UK. Results remained stable across different sensitivity analyses, with societal cost-effectiveness improved for those (self-)employed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S2056472426110217_as5\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We observed potentially meaningful health and economic benefits of closely monitored antidepressant treatment, as implemented in both treatment and control arms of the PReDicT trial. The PReDicT test itself had some added benefits in improved capabilities and productivity, however, with great uncertainty and country-level variations in cost-effectiveness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1192\/bjo.2026.11021","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T10:03:04Z","timestamp":1776074584000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":0,"title":["The cost-effectiveness of predictive algorithm guided primary antidepressant treatment: economic evaluation of the multinational PReDicT randomised controlled trial"],"prefix":"10.1192","volume":"12","author":[{"given":"Nata\u0161a","family":"Peri\u0107","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05n3x4p02","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical University of Vienna"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Mayer","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05n3x4p02","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical University of Vienna"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2696-2553","authenticated-orcid":false,"given":"Timea","family":"Helter","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05n3x4p02","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical University of Vienna"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Deckert","sequence":"additional","affiliation":[{"name":"University Hospital of W\u00fcrzburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Gorwood","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9"},{"name":"Sainte-Anne Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Perez","sequence":"additional","affiliation":[{"name":"Hospital del Mar Medical Research Institute (IMIM)"},{"name":"Biomedical Research Networking Center in Mental Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Reif","sequence":"additional","affiliation":[{"name":"University Hospital Frankfurt \u2013 Goethe University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6072-0358","authenticated-orcid":false,"given":"Henricus G.","family":"Ruhe","sequence":"additional","affiliation":[{"name":"Radboud UMC"},{"name":"Radboud University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick J.","family":"Veltman","sequence":"additional","affiliation":[{"name":"Amsterdam Neuroscience, Amsterdam UMC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"van Schaik","sequence":"additional","affiliation":[{"name":"Amsterdam Public Health Research Institute, Amsterdam UMC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2910-4121","authenticated-orcid":false,"given":"Richard Keith","family":"Morriss","sequence":"additional","affiliation":[{"name":"University of Nottingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Beckenstrom","sequence":"additional","affiliation":[{"name":"P1vital Ltd"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard R.","family":"Dawson","sequence":"additional","affiliation":[{"name":"P1vital Ltd"},{"name":"P1vital Products Limited"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin T.","family":"Dourish","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Dias","sequence":"additional","affiliation":[{"name":"P1vital Products Limited"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Kingslake","sequence":"additional","affiliation":[{"name":"P1vital Ltd"},{"name":"P1vital Products Limited"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Browning","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Oxford"},{"name":"Warneford Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9279-8627","authenticated-orcid":false,"given":"Judit","family":"Simon","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05n3x4p02","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical University of Vienna"},{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"S2056472426110217_ref10","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-clinpsy-050817-084746"},{"key":"S2056472426110217_ref31","unstructured":"31 Strohmaier, C , Zechmeister-Koss, I. Threshold Values in Health Economic Evaluations and Decision-making: AIHTA Project Report No. 163 . Austrian Institute for Health Technology Assessment, 2024 (https:\/\/eprints.aihta.at\/1549\/1\/HTA-Projektbericht_Nr.163.pdf)."},{"key":"S2056472426110217_ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-021-01379-w"},{"key":"S2056472426110217_ref32","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.187.2.106"},{"key":"S2056472426110217_ref3","volume-title":"Health at a Glance: Europe 2018","year":"2018"},{"key":"S2056472426110217_ref30","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4067"},{"key":"S2056472426110217_ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19052858"},{"key":"S2056472426110217_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32802-7"},{"key":"S2056472426110217_ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-012-0293-5"},{"key":"S2056472426110217_ref8","unstructured":"8 National Institute for Health and Care Excellence. Depression in Adults: Treatment and Management. NICE Guideline NG222. NICE, 2022 (https:\/\/www.nice.org.uk\/guidance\/ng222)."},{"key":"S2056472426110217_ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-014-0193-3"},{"key":"S2056472426110217_ref33","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X98018002S09"},{"key":"S2056472426110217_ref38","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2021-300334"},{"key":"S2056472426110217_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2013.09.019"},{"key":"S2056472426110217_ref34","volume-title":"Unit Costs of Health and Social Care 2024 Manual","author":"Jones","year":"2025"},{"key":"S2056472426110217_ref26","unstructured":"26 European Commission. Exchange Rate (InforEuro) . European Commission, 2018 (https:\/\/ec.europa.eu\/budget\/graphs\/inforeuro.html)."},{"key":"S2056472426110217_ref28","volume-title":"Trimbos\/iMTA Questionnaire for Costs Associated with Psychiatric Illness (TiC-P)","author":"Hakkaart-van Roijen","year":"2010"},{"key":"S2056472426110217_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(21)00395-3"},{"key":"S2056472426110217_ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjment-2024-301021"},{"key":"S2056472426110217_ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-018-0615-8"},{"key":"S2056472426110217_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2022.10.001"},{"key":"S2056472426110217_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.02.008"},{"key":"S2056472426110217_ref13","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2019-300109"},{"key":"S2056472426110217_ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-017-2247-2"},{"key":"S2056472426110217_ref25","volume-title":"HEQ (Health Economics Questionnaire) (Version v5.0 (08-09-2016))","author":"Simon","year":"2016"},{"key":"S2056472426110217_ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-021-00981-z"},{"key":"S2056472426110217_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2024.152467"},{"key":"S2056472426110217_ref35","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.11.1905"},{"key":"S2056472426110217_ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-018-0955-5"},{"key":"S2056472426110217_ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02204-0"},{"key":"S2056472426110217_ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-013-0084-z"},{"key":"S2056472426110217_ref39","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19063500"},{"key":"S2056472426110217_ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-024-00905-0"},{"key":"S2056472426110217_ref9","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.11.1905"},{"key":"S2056472426110217_ref27","unstructured":"27 Eurostat. Time Spent, Participation Time and Participation Rate in the Main Activity by Sex and Household Composition [tus_00hhstatus] . Eurostat, 2018 (https:\/\/ec.europa.eu\/eurostat\/de\/web\/products-datasets\/-\/TUS_00HHSTATUS)."},{"key":"S2056472426110217_ref4","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796019000180"},{"key":"S2056472426110217_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2018.11.1102"},{"key":"S2056472426110217_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(25)00138-5"},{"key":"S2056472426110217_ref18","unstructured":"18 National Institute for Health Care Excellence. NICE Technology Appraisal and Highly Specialised Technologies Guidance: The Manual \u2013 PMG36. NICE, 2022 (https:\/\/www.nice.org.uk\/process\/pmg36)."},{"key":"S2056472426110217_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.01.003"}],"container-title":["BJPsych Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2056472426110217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T10:03:13Z","timestamp":1776074593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2056472426110217\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["S2056472426110217"],"URL":"https:\/\/doi.org\/10.1192\/bjo.2026.11021","relation":{},"ISSN":["2056-4724"],"issn-type":[{"value":"2056-4724","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"\u00a9 The Author(s), 2026. Published by Cambridge University Press on behalf of Royal College of Psychiatrists","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e107"}}